Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.200
-0.050 (-4.00%)
Jun 8, 2026, 4:00 PM EDT - Market closed
Immuron Market Cap
Immuron has a market cap or net worth of $9.8 million as of June 8, 2026. Its market cap has increased by 4.21% in one year.
Market Cap
9.80M
Enterprise Value
2.80M
1-Year Change
4.21%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $9.80M, a decrease of -65.14%. That is a compound annual growth rate of -11.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 10.20M | 126.67% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 10.75M |
| BioCardia | 10.46M |
| HCW Biologics | 10.38M |
| NextCure | 10.07M |
| Jupiter Neurosciences | 10.03M |
| Intensity Therapeutics | 10.02M |
| Kairos Pharma | 9.64M |
| Aptorum Group | 9.53M |